BRIEF-Repros' secondary hypogonadism treatment filing accepted by European authorities
October 05, 2016 at 10:43 AM EDT
* Repros announces acceptance of dossier for Enclomiphene for secondary hypogonadism by European authorities
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.